Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial

BACKGROUND: Convalescent plasma has been one of the most common treatments for COVID-19, but most clinical trial data to date have not supported its efficacy. RESEARCH QUESTION: Is rigorously selected COVID-19 convalescent plasma with neutralizing anti-SARS-CoV-2 antibodies an efficacious treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Self, Wesley H., Wheeler, Allison P., Stewart, Thomas G., Schrager, Harry, Mallada, Jason, Thomas, Christopher B., Cataldo, Vince D., O’Neal, Hollis R., Shapiro, Nathan I., Higgins, Conor, Ginde, Adit A., Chauhan, Lakshmi, Johnson, Nicholas J., Henning, Daniel J., Jaiswal, Stuti J., Mammen, Manoj J., Harris, Estelle S., Pannu, Sonal R., Laguio-Vila, Maryrose, El Atrouni, Wissam, de Wit, Marjolein, Hoda, Daanish, Cohn, Claudia S., McWilliams, Carla, Shanholtz, Carl, Jones, Alan E., Raval, Jay S., Mucha, Simon, Ipe, Tina S., Qiao, Xian, Schrantz, Stephen J., Shenoy, Aarthi, Fremont, Richard D., Brady, Eric J., Carnahan, Robert H., Chappell, James D., Crowe, James E., Denison, Mark R., Gilchuk, Pavlo, Stevens, Laura J., Sutton, Rachel E., Thomsen, Isaac, Yoder, Sandra M., Bistran-Hall, Amanda J., Casey, Jonathan D., Lindsell, Christopher J., Wang, Li, Pulley, Jill M., Rhoads, Jillian P., Bernard, Gordon R., Rice, Todd W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:
Chest Infections: Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247217/
https://www.ncbi.nlm.nih.gov/pubmed/35780813
http://dx.doi.org/10.1016/j.chest.2022.06.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247217/
https://www.ncbi.nlm.nih.gov/pubmed/35780813
http://dx.doi.org/10.1016/j.chest.2022.06.029

Ejemplares similares